Mobia Medical, Inc. (MOBI)
Market Closed
10 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 73
+0.49
+4.0033%
$
423.26M Market Cap
- P/E Ratio
- Div Yield
177,814 Volume
- Eps
$ 12.24
Previous Close 
Want to track MOBI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mobia Medical poised for commercial expansion, BofA says in initial coverage
Mobia Medical (NASDAQ:MOBI) was initiated with a ‘Buy' rating and a $16 price target by Bank of America, which cited the company's growth potential in stroke recovery treatment and a large addressable market for its Vivistim system. Mobia's Vivistim therapy combines rehabilitation exercises with a vagus nerve stimulation (VNS) device designed to help chronic stroke survivors improve upper-limb function.
Proactiveinvestors | 2 months ago
